JCLCX | PACAX | JCLCX / PACAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 31 years | - |
Gain YTD | 5.397 | 10.123 | 53% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 1.65B | 576M | 287% |
Annual Yield % from dividends | 2.84 | 2.18 | 130% |
Returns for 1 year | 10.75 | 16.76 | 64% |
Returns for 3 years | -6.50 | -2.74 | 237% |
Returns for 5 years | 3.25 | 11.40 | 29% |
Returns for 10 years | 5.88 | 15.39 | 38% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GPGCX | 16.98 | 0.11 | +0.65% |
Grandeur Peak Global Contrarian Instl | |||
JHLVX | 62.38 | N/A | N/A |
JHancock Fundamental Large Cap Core C | |||
FIUSX | 38.16 | N/A | N/A |
Delaware Opportunity A | |||
NSFEX | 11.43 | -0.04 | -0.35% |
Natixis Target Retirement 2025 N | |||
ETNHX | 34.80 | -0.82 | -2.30% |
Eventide Healthcare & Life Sciences N |